Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04404569
Title Continued Treatment for Participants Enrolled in Studies of BXQ-350
Recruitment Enrolling by invitation
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bexion Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

Therapies

BXQ-350

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.